Dynamic Changes in the Gut Microbiota Composition during Adalimumab Therapy in Patients with Ulcerative Colitis: Implications for Treatment Response Prediction and Therapeutic Targets
Author:
Affiliation:
1. Chung-Ang University
2. Chung-Ang University College of Medicine
3. Kyung Hee University Hospital, Department of Gastroenterology
4. The Catholic University of Korea St. Vincent’s Hospital
5. Yonsei University College of Medicine
Abstract
Background Little is known about the changes in the gut microbiota composition during anti-tumor necrosis factor-alpha (anti TNF-α) therapy. This study aimed to investigate the dynamics of gut microbiome changes during anti TNF-α (adalimumab) therapy in patients with ulcerative colitis (UC). Results The microbiota composition was affected by the disease severity and extent in patients with UC. Regardless of clinical remission status at each time point, patients with UC exhibited microbial community distinctions from healthy controls. Distinct amplicon sequence variants (ASVs) differences were identified throughout the course of ADA treatment at each time point. A notable reduction in gut microbiome dissimilarity was observed only in remitters. Remitters demonstrated a decrease in the relative abundances of Burkholderia-Caballeronia-Paraburkholderia and Staphylococcus, accompanied by an increase in Bifidobacterium and Dorea as the treatment progressed. Given the distribution of the 48 ASVs with high or low relative abundances in the pre-treatment samples according to clinical remission at week 8, a clinical remission at week 8 with a sensitivity and specificity of 72.4% and 84.3%, respectively, was predicted on the receiver operating characteristic curve (area under the curve, 0.851). Conclusions The gut microbiota undergoes diverse changes according to the treatment response during ADA treatment. These changes provide insights into predicting treatment responses to ADA and offer new therapeutic targets for UC.
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Environmental risk factors for inflammatory bowel diseases: Evidence based literature review;Abegunde AT;World J Gastroenterol,2016
2. European Crohn's and Colitis Organisation Topical Review on Environmental Factors in IBD;Maaser C;J Crohns Colitis,2017
3. Inflammatory Bowel Diseases: Review of Known Environmental Protective and Risk Factors Involved;Sloot KWJ;Inflamm Bowel Dis,2017
4. Understanding and Preventing the Global Increase of Inflammatory Bowel Disease;Kaplan GG;Gastroenterology,2017
5. Review article: changes in the epidemiology of inflammatory bowel disease-clues for aetiology;Bernstein CN;Aliment Pharmacol Ther,2017
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3